Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Celgene Corporation

Home Clinical Trial Sponsors and OrganizationsCelgene Corporation

Celgene Corporation

ACTIVE

4503 Glencoe Ave, Marina Del Rey, California, United Stateswww.bms.comSubsidiary10,001+ employeesEstablished: 1986-01-01

Also known as:

celgene corp.

Part of Bristol Myers Squibb Co.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

77

20 active

Approvals

13

Total approvals

Agencies

2

Regulatory bodies

Founded

1986

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

48

62.3%

Phase 3

15

19.5%

Phase 2

13

16.9%

Phase 1/2

1

1.3%

Trial Status Distribution

Active, not recruiting

20

26.0%

Completed

6

7.8%

Recruiting

51

66.2%

Clinical Trials

Trials sponsored by this organization (77)

Study of Zola-cel (BMS-986353), CD19 NEX-T CAR T Cells in Autoimmune Cytopenia (Breakfree-AiCE)

Aug 20263 participants

Study of BMS-986353, CD19-CAR T Cells, versus SoC in Participants with Active SSc (Breakfree-SSc)

Jun 202637 participants

A clinical trial to evaluate the safety and effectiveness of a combination of either AG-12or AG-221 tablets with azacitidine injections in patients withnewly diagnosed Acute Myeloid Leukemia (AML) and who have mutations in enzymes isocitrate dehydrogenase 1 or 2 (IDH 1 or IDH2) and are not candidates to receive intensive induction chemotherapy.

Active, not recruiting

May 2024138 participants

A clinical trial to evaluate if CC-486 plus pembrolizumab works and is safe in patients with advanced or metastatic non-small cell lung cancer who have previously received platinum containing treatment.

Active, not recruiting

May 20241 participant

A study to decide what is the highest dose of CC-220 to take alone and with other standard of care treatments to assess the side effects, effectiveness and how the body deals with the drug in patients with multiple myeloma

Active, not recruiting

May 2024498 participants

A clinical study that compares a treatment with Iberdomide, Daratumumab and Dexamethasone against a treatment with Daratumumab, Bortezomib, and Dexamethasone in patients with a non-responsive or progressive blood cancer called Multiple Myeloma

Active, not recruiting

May 2024864 participants

CC-92480-MM-002 A Phase 1/2, Multicenter, Open-label, Study to Determine the Recommended Dose and Regimen, and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination with Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

Active, not recruiting

Apr 2024190 participants

A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma(RRMM) (KarMMa-3)

Active, not recruiting

Apr 2024386 participants

Page 1 of 10

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

2

Approvals

FDA

Food and Drug Administration

11

Approvals

Recent Approvals

Paclitaxel For Injection (Albumin Bound)

News

No news articles found

On this page

Overview
Clinical Trials77
Approvals13
News

Back to Organizations